Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Clinical trial NCT03767348 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03767348
Sponsor: Replimune, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)Cutaneous Melanoma

Start date: 2017-09-20
Primary completion: 2028-06-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.